Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1.HCWs not directly involved in patient care (facility manager, supervisory staff not physically present in the patient care areas) <br/ >2. A immunodeficiency state (including primary immunodeficiency, HIV infection, chemotherapy or high-dose steroid therapy (more than or equal to 20 mg for more than or equal to 2 weeks),non-biological immunosuppressant (also known as DMARDS), biological agents (such as monoclonal antibodies against tumor necrosis factor (TNF)-alpha) <br/ >3. Pregnancy <br/ >4.Malignancy <br/ >5.Active skin disease such as eczema, dermatitis or psoriasis at or near the site of vaccination. <br/ >6.Previously had a SARS-CoV-2 positive test result <br/ >7.BCG vaccine received in the past one year <br/ >

1.HCWs not directly involved in patient care (facility manager, supervisory staff not physically present in the patient care areas) <br/ >2. A immunodeficiency state (including primary immunodeficiency, HIV infection, chemotherapy or high-dose steroid therapy (more than or equal to 20 mg for more than or equal to 2 weeks),non-biological immunosuppressant (also known as DMARDS), biological agents (such as monoclonal antibodies against tumor necrosis factor (TNF)-alpha) <br/ >3. Pregnancy <br/ >4.Malignancy <br/ >5.Active skin disease such as eczema, dermatitis or psoriasis at or near the site of vaccination. <br/ >6.Previously had a SARS-CoV-2 positive test result <br/ >7.BCG vaccine received in the past one year <br/ >

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Oct. 26, 2020, 8:29 a.m. oms

1.HCWs not directly involved in patient care (facility manager, supervisory staff not physically present in the patient care areas) <br/ >2. A immunodeficiency state (including primary immunodeficiency, HIV infection, chemotherapy or high-dose steroid therapy (more than or equal to 20 mg for more than or equal to 2 weeks),non-biological immunosuppressant (also known as DMARDS), biological agents (such as monoclonal antibodies against tumor necrosis factor (TNF)-alpha) <br/ >3. Pregnancy <br/ >4.Malignancy <br/ >5.Active skin disease such as eczema, dermatitis or psoriasis at or near the site of vaccination. <br/ >6.Previously had a SARS-CoV-2 positive test result <br/ >7.BCG vaccine received in the past one year <br/ >

1.HCWs not directly involved in patient care (facility manager, supervisory staff not physically present in the patient care areas) <br/ >2. A immunodeficiency state (including primary immunodeficiency, HIV infection, chemotherapy or high-dose steroid therapy (more than or equal to 20 mg for more than or equal to 2 weeks),non-biological immunosuppressant (also known as DMARDS), biological agents (such as monoclonal antibodies against tumor necrosis factor (TNF)-alpha) <br/ >3. Pregnancy <br/ >4.Malignancy <br/ >5.Active skin disease such as eczema, dermatitis or psoriasis at or near the site of vaccination. <br/ >6.Previously had a SARS-CoV-2 positive test result <br/ >7.BCG vaccine received in the past one year <br/ >